Health Care and Life Sciences Companies Should Prioritize Corporate Compliance

A recent program sponsored by the Seton Hall Law Center for Health and Pharmaceutical Law & Policy urged health care and life sciences companies to place a high degree of emphasis on developing and maintaining effective corporate compliance programs.

HealthReformWatch.com, a blog sponsored by above referenced Seton Hall Law Center has a full recap of the event and the topics that were discussed.

The participants focused on the financial challenges and potential exposure for board members of health care and life sciences entities in maintaining an effective compliance program in order to minimize noncompliant behavior and corporate liability risks. Current trends in HHS Corporate Integrity Agreements (CIA’s) have shown a movement toward imposing personal liability on boards of directors for failure to ensure that a company has an effective corporate compliance program.

Read more at HealthReformWatch.com.

Tags: corporate compliance, corporate compliance programs, health care, health care compliance, life sciences, Pharma Compliance, seton hall law center